GlassScriptPhysician profile
Evan Kelton Dackowski
NPI 1275119661
$2,966.47
in general payments reported to CMS, 2019-2025
5 companies · $2,777 in 2025
The $2,777 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $99.99 · 2024: $89.18 · 2025: $2,777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,593 · Food and Beverage: $1,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,592.92 |
| Food and Beverage | $1,273.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $2,458.24 | 2024-2025 | Istent Infinite, Travoprost Intraocular Implant - Idose, Radius Xr |
| Alcon Vision LLC | $194.09 | 2025 | Unity, Clareon, Rocklatan |
| New World Medical,INC. | $174.11 | 2024-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Abbvie INC. | $99.99 | 2022 | |
| Bausch & Lomb Americas INC. | $40.04 | 2025 | Vyzulta, Envista Mx60 Iol, Amvisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Dackowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.